Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Apr 2013 07:00

RNS Number : 9501C
Cello Group plc
23 April 2013
 



TR-1[i]: notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached[ii]:

 

Cello Group Plc Ord GBP0.1

2. Reason for the notification (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation[iii]:

Universities Superannuation Scheme Ltd

4. Full name of shareholder(s) (if different from 3.)[iv]:

5. Date of the transaction (and date on which the threshold is crossed or reached if different)[v]:

 18/4/2013

6. Date on which issuer notified:

22/4/2013

7. Threshold(s) that is/are crossed or reached:

4%

8. Notified details:

 

 

 

A: Voting rights attached to shares

Class/type of shares

 if possible using the ISIN CODE

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii]

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights ix

% of voting rights

Direct

Direct x

Indirect xi

Direct

Indirect

Sedol:

B031076

4,012,952

 

4,012,952

 

 

2,787,952

 

2,787,952

3.38

 

B: Financial Instruments

Resulting situation after the triggering transaction xii

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period/ Date xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

Total (A+B)

Number of voting rights

% of voting rights

 

2,787,952

3.38

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable xv:

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

14. Contact name:

Philip Brayne

15. Contact telephone number:

 0151 227 4711

AnnexNotification Of Major Interests In Shares xvi

A: Identity of the person or legal entity subject to the notification obligation

Full name (including legal form for legal entities)

Universities Superannuation Scheme Ltd

Contact address (registered office for legal entities)

2nd Floor Royal Liver Building

Liverpool L3 1PY

Phone number

0151 227 4711

Other useful information (at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable xvii

Full name

Contact address

Phone number

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

 

C: Additional information

 

 

 

Notes

 

[i] This form is to be sent to the issuer or underlying issuer and to be filed with the competent authority.

[ii] Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

[iii] This should be the full name of (a) the shareholder; (b) the person acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to in DTR5.2.1 (a), or (d) the direct or indirect holder of financial instruments entitled to acquire shares already issued to which voting rights are attached, as appropriate.

In relation to the transactions referred to in points DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

- in the circumstances foreseen in DTR5.2.1 (b), the person that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

- in the circumstances foreseen in DTR 5.2.1 (c), the person holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and person lodging the collateral under these conditions;

- in the circumstances foreseen in DTR5.2.1(d), the person who has a life interest in shares if that person is entitled to exercise the voting rights attached to the shares and the person who is disposing of the voting rights when the life interest is created;

- in the circumstances foreseen in DTR5.2.1 (e), the parent undertaking and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

- in the circumstances foreseen in DTR5.2.1 (g), the person that controls the voting rights;

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion.

[iv] Applicable in the cases provided for in DTR 5.2.1 (b) to (h). This should be the full name of the shareholder or holder of financial instruments who is the counterparty to the natural person or legal entity referred to in DTR5.2.

[v] The date of the transaction should normally be, in the case of an on exchange transaction, the date on which the matching of orders occurs; in the case of an off exchange transaction, date of the entering into an agreement. 

The date on which threshold is crossed should normally be the date on which the acquisition, disposal or possibility to exercise voting rights takes effect (see DTR 5.1.1R (3)). For passive crossings, the date when the corporate event took effect.

These dates will usually be the same unless the transaction is subject to a condition beyond the control of the parties.

[vi] Please refer to the situation disclosed in the previous notification, In case the situation previous to the triggering transaction was below 3%, please state 'below 3%'.

vii If the holding has fallen below the minimum threshold , the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is less than 3%.

For the case provided for in DTR5.2.1(a), there should be no disclosure of individual holdings per party to the agreement unless a party individually crosses or reaches an Article 9 threshold. This applies upon entering into, introducing changes to or terminating an agreement.

viii Direct and indirect

ix In case of combined holdings of shares with voting rights attached 'direct holding' and voting rights 'indirect holdings', please split the voting rights number and percentage into the direct and indirect columns-if there is no combined holdings, please leave the relevant box blank.

X Voting rights attached to shares in respect of which the notifying party is a direct shareholder (DTR 5.1)

xi Voting rights held by the notifying party as an indirect shareholder (DTR 5.2.1)

xii If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

xiii date of maturity / expiration of the finical instrument i.e. the date when the right to acquire shares ends.

xiv If the financial instrument has such a period-please specify the period- for example once every three months starting from the [date]

xv The notification should include the name(s) of the controlled undertakings through which the voting rights are held. The notification should also include the amount of voting rights and the percentage held by each controlled undertaking, insofar as individually the controlled undertaking holds 3% or more, and insofar as the notification by the parent undertaking is intended to cover the notification obligations of the controlled undertaking.

xvi This annex is only to be filed with the competent authority.

xvii Whenever another person makes the notification on behalf of the shareholder or the natural person/legal entity referred to in DTR5.2 and DTR5.3.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBRGDSSBDBGXD
Date   Source Headline
11th Aug 20201:38 pmRNSForm 8.3 - Cello Health Plc
11th Aug 202012:05 pmRNSForm 8.3 - Cello Health Plc
11th Aug 202011:34 amRNSForm 8.3 - [Cello Health plc]
11th Aug 202010:07 amRNSScheme of Arrangement becomes Effective
11th Aug 20208:49 amPRNForm 8.3 - Cello Health Plc
11th Aug 20207:30 amRNSSuspension - Cello Health Plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 202012:12 pmRNSRelevant Securities in Issue
10th Aug 202011:02 amRNSForm 8.3 - Cello Health PLC
10th Aug 20208:54 amRNSExercise of Options
10th Aug 20208:06 amRNSForm 8.5 (EPT/NON-RI)
7th Aug 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
7th Aug 20203:04 pmRNSCourt Sanction of Scheme
7th Aug 202012:52 pmRNSAdditional Block Listing of Ordinary Shares
6th Aug 202011:01 amRNSForm 8.3 - Cello Health PLC
5th Aug 20201:34 pmRNSForm 8.3 - Cello Health Plc
4th Aug 20205:30 pmRNSCello Health
4th Aug 202012:39 pmRNSForm 8.3 - Cello Health PLC
4th Aug 20208:21 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202012:57 pmRNSResults of Court Meeting and General Meeting
3rd Aug 202010:53 amRNSForm 8.3 - CELLO GROUP PLC
31st Jul 202012:39 pmRNSForm 8.3 - CELLO GROUP PLC
31st Jul 202011:46 amRNSForm 8.3 - Cello Health PLC
31st Jul 20208:34 amRNSForm 8.5 (EPT/NON-RI)
31st Jul 20207:58 amRNSForm 8.3 - Cello Health PLC
30th Jul 20205:11 pmRNSHolding(s) in Company
30th Jul 20208:03 amRNSForm 8.3 - Cello Health Plc
29th Jul 202012:49 pmRNSHolding(s) in Company
29th Jul 20208:30 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 20206:18 pmRNSUpdate on letters of intent
28th Jul 20203:17 pmRNSForm 8.3 - CELLO HEALTH PLC
28th Jul 20202:46 pmRNSForm 8.3 - Cello Health PLC
28th Jul 20202:04 pmRNSNotification of Major Holdings
28th Jul 20201:24 pmRNSCELLO HEALTH PLC ORD GBP0.10
28th Jul 202011:36 amGNWForm 8.3 - [Cello Health plc] - (HHL)
28th Jul 202011:17 amRNSForm 8.3 - Cello Health Plc
28th Jul 20208:45 amRNSForm 8.5 (EPT/NON-RI)
27th Jul 20203:17 pmRNSForm 8.3 - [CELLO HEALTH PLC
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20203:29 pmRNSForm 8.3 - Cello Health PLC
22nd Jul 202012:33 pmRNSForm 8.3 - Cello Health PLC
22nd Jul 202011:38 amRNSFORM 8.3 - Cello Health Plc
21st Jul 20203:15 pmBUSForm 8.3 - Cello Health plc
21st Jul 20202:35 pmRNSForm 8.3 - Cello Health PLC
21st Jul 202012:18 pmRNSBlock Listing Update & Total Voting Rights
21st Jul 20207:00 amRNSHolding(s) in Company
20th Jul 20203:15 pmBUSForm 8.3 - Cello Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.